The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting-Reference-Cited by-同舟云学术

The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting

Published:2021-02-01 Issue:2 Volume:25 Page:115-139
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Bhandari Ranjana¹,Kaur Japneet¹,Kaur Simerpreet¹,Kuhad Anurag¹

Affiliation:

1. Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Panjab University, Chandigarh, India

Funder

the Department of Science & Technology, Govt of India

All-India Council for Technical Education

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2021.1887141

Reference277 articles.

1. Psychiatric Disorders and Oxidative Injury: Antioxidant Effects of Zolpidem Therapy disclosed In Silico

2. Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention

3. Oxidative/Nitrosative Stress in Psychiatric Disorders: Are We There Yet?

4. Endogenous Antioxidants: A Review of their Role in Oxidative Stress

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the role of siRNA in anxiety and depression;European Journal of Pharmacology;2024-10

2. Repeated Sulforaphane Treatment Reverses Depressive-like Behavior and Exerts Antioxidant Effects in the Olfactory Bulbectomy Model in Mice;Pharmaceuticals;2024-06-11

3. Are you feeling comfortable? – Measuring clinical hormesis;Translational Medicine of Aging;2024

4. The Janus face of antipsychotics in glial cells: Focus on glioprotection;Experimental Biology and Medicine;2023-11

5. The Gut–Brain Axis as a Therapeutic Target in Multiple Sclerosis;Cells;2023-07-17